Helical membrane peptides to modulate cell function

被引:39
作者
Beevers, Andrew J. [1 ]
Dixon, Ann M. [1 ]
机构
[1] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England
基金
英国医学研究理事会;
关键词
PAPILLOMAVIRUS E5 PROTEIN; FACTOR-BETA RECEPTOR; HUMAN-IMMUNODEFICIENCY-VIRUS; NICOTINIC CHOLINERGIC-RECEPTOR; LIPID-BILAYER-MEMBRANES; GROWTH-FACTOR RECEPTOR; TRANSMEMBRANE DOMAIN; ANTIMICROBIAL PEPTIDES; ION CHANNELS; IN-VIVO;
D O I
10.1039/b912944h
中图分类号
O6 [化学];
学科分类号
070301 [无机化学];
摘要
In recent years there has been an abundance of research into the potential of helical peptides to influence cell function. These peptides have been used to achieve a variety of different outcomes from cell repair to cell death, depending upon the peptide sequence and the nature of its interactions with cell membranes and membrane proteins. In this critical review, we summarise several mechanisms by which helical peptides, acting as either transporters, inhibitors, agonists or antibiotics, can have significant effects on cell membranes and can radically affect the internal mechanisms of the cell. The various approaches to peptide design are discussed, including the role of naturally-occurring proteins in the design of these helical peptides and current breakthroughs in the use of non-natural (and therefore more stable) peptide scaffolds. Most importantly, the current successful applications of these peptides, and their potential uses in the field of medicine, are reviewed.
引用
收藏
页码:2146 / 2157
页数:12
相关论文
共 133 条
[1]
Adams PD, 1996, PROTEINS, V26, P257, DOI 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.3.CO
[2]
2-O
[3]
COMPUTATIONAL SEARCHING AND MUTAGENESIS SUGGEST A STRUCTURE FOR THE PENTAMERIC TRANSMEMBRANE DOMAIN OF PHOSPHOLAMBAN [J].
ADAMS, PD ;
ARKIN, IT ;
ENGELMAN, DM ;
BRUNGER, AT .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (02) :154-162
[4]
Mechanisms of Antimicrobial, Cytolytic, and Cell-Penetrating Peptides: From Kinetics to Thermodynamics [J].
Almeida, Paulo F. ;
Pokorny, Antje .
BIOCHEMISTRY, 2009, 48 (34) :8083-8093
[5]
Andreev OA, 2009, CHIM OGGI, V27, P34
[6]
BAKER MA, 1993, CANCER RES, V53, P3052
[7]
Transmembrane peptides as inhibitors of ErbB receptor signaling [J].
Bennasroune, A ;
Fickova, M ;
Gardin, A ;
Dirrig-Grosch, S ;
Aunis, D ;
Crémel, G ;
Hubert, P .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (07) :3464-3474
[8]
DETERMINATION OF THE 3-DIMENSIONAL STRUCTURE OF THE ANTENNAPEDIA HOMEODOMAIN FROM DROSOPHILA IN SOLUTION BY H-1 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
BILLETER, M ;
QIAN, Y ;
OTTING, G ;
MULLER, M ;
GEHRING, WJ ;
WUTHRICH, K .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 214 (01) :183-197
[9]
Design, synthesis, and characterization of peptide nanostructures having ion channel activity [J].
Biron, E ;
Otis, F ;
Meillon, JC ;
Robitaille, M ;
Lamothe, J ;
Van Hove, P ;
Cormier, ME ;
Voyer, N .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (06) :1279-1290
[10]
The uptake of cholesterol at the small-intestinal brush border membrane is inhibited by apolipoproteins [J].
Boffelli, D ;
Compassi, S ;
Werder, M ;
Weber, FE ;
Phillips, MC ;
Schulthess, G ;
Hauser, H .
FEBS LETTERS, 1997, 411 (01) :7-11